ScienceDirect® Home Skip Main Navigation Links
You have guest access to ScienceDirect. Find out more.
 
Home
Browse
My Settings
Alerts
Help
 Quick Search
 Search tips (Opens new window)
    Clear all fields    
 
Font Size: Decrease Font Size  Increase Font Size
 Abstract - selected
Article
Purchase PDF (489 K)

Article Toolbox
 
 
 
Related Articles in ScienceDirect
View More Related Articles
 
View Record in Scopus
 
doi:10.1016/j.ejmech.2006.12.036    
How to Cite or Link Using DOI (Opens New Window)

Copyright © 2007 Elsevier Masson SAS All rights reserved.

Original article

Synthesis and antioxidant activity of new homocarnosine β-cyclodextrin conjugates

Purchase the full-text article



References and further reading may be available for this article. To view references and further reading you must purchase this article.

Angela Maria Amorinia, Francesco Belliaa, Valentina Di Pietrob, Bruno Giardinab, Diego La Mendolac, Giuseppe Lazzarinoa, Salvatore Sortinoa, Barbara Tavazzib, Enrico Rizzarellia, Corresponding Author Contact Information, E-mail The Corresponding Author and Graziella Vecchioa

aDipartimento di Scienze Chimiche, Università di Catania, V.le A. Doria 6, 95125 Catania, Italy

bIstituto di Biochimica e Biochimica Clinica, Università Cattolica “Sacro Cuore”, Largo F. Vito 1, 00164 Roma, Italy

cIstituto di Biostrutture e Bioimmagini, CNR, Catania, V.le A. Doria 6, 95125 Catania, Italy


Received 5 December 2006; 
accepted 29 December 2006. 
Available online 21 January 2007.

Abstract

Several in vitro and in vivo studies have suggested that carnosine (β-alanil-l-histidine) and homocarnosine (β-aminobutyril-l-histidine) can act as scavengers of reactive oxygen species. β-Cyclodextrin was functionalized with homocarnosine, obtaining the following new bioconjugate isomers: 6A-[(4-{[(1S)-1-carboxy-2-(1H-imidazol-4-yl)ethyl]amino}-4-oxobutyl)amino]-6A-deoxy-β-cyclodextrin and (2AS,3AR)-3A-[(4-{[(1S)-1-carboxy-2-(1H-imidazol-4-yl)ethyl]amino}-4-oxobutyl)amino]-3A-deoxy-β-cyclodextrin. Pulse radiolysis investigations show that the β-cyclodextrin homocarnosine bioconjugates are scavengers of radical dotOH radicals because of the formation of stable imidazole-centered radicals and the scavenger ability of glucose molecules of the macrocycle. The ability of these new β-cyclodextrin derivatives to inhibit the copper(II) driven LDL oxidation was determined in comparison with that displayed by the analogous carnosine derivatives. Both the β-cyclodextrin carnosine isomers show a higher protective effect than that of free dipeptide and homocarnosine derivatives, bringing into light the role of the β-CD cavity.

The ability of these new β-cyclodextrin derivatives to inhibit the copper(II) driven LDL oxidation was determined in comparison with that displayed by the analogous carnosine derivatives. Both the β-cyclodextrin carnosine isomers show a higher protective effect than that of free dipeptide and homocarnosine derivatives, bringing into light the role of the β-CD cavity.

Graphical abstract

Full-size image

The ability of new β-cyclodextrin homocarnosine conjugates to scavenger hydroxyl radicals and to inhibit LDL oxidation makes them promising agents against harmful oxygen species.

Keywords: β-Cylodextrin; Homocarnosine; Carnosine; Low density lipoprotein; Pulse radiolysis

Article Outline

1. Introduction
2. Experimental procedures
2.1. Chemicals
2.1.1. Synthesis of 6A-[(4-{[(1S)-1-carboxy-2-(1H-imidazol-4-yl)ethyl]amino}-4-oxobutyl)amino]-6A-deoxy-β-cyclodextrin (CDHC6)
2.1.2. Synthesis of (2AS,3AR)-3A-[(4-{[(1S)-1-carboxy-2-(1H-imidazol-4-yl)ethyl]amino}-4-oxobutyl)amino]-3A-deoxy-β-cyclodextrin CDHC3
2.2. Pulse radiolysis
2.3. Oxidation of human LDL
2.4. HPLC analysis of MDA
3. Results and discussion
3.1. Synthesis and NMR characterization
3.1.1. NMR spectra of CDHC6
3.1.2. NMR spectra of CDHC3
3.2. Pulse radiolysis
3.2.1. Reaction of radical dotOH radicals with CDHC6 and CDHC3
3.3. LDL oxidation
4. Conclusions
Acknowledgements
References









Corresponding Author Contact InformationCorresponding author. Tel.: +39 0957385070; fax: +39 095337678.

 
Home
Browse
My Settings
Alerts
Help
Elsevier.com (Opens new window)
About ScienceDirect  |  Contact Us  |  Information for Advertisers  |  Terms & Conditions  |  Privacy Policy
Copyright © 2008 Elsevier B.V. All rights reserved. ScienceDirect® is a registered trademark of Elsevier B.V.